Jason P Shanley

USPTO Granted Patents = 12 (Patent Applications = 2)

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 7 (Patent Applications = 8)

Average Co-Inventor Count = 12.2

ph-index = 5

Forward Citations = 73(Granted Patents)

Company Filing History:

Abbott Laboratories Corporation

patents

3 out of 292

Enanta Pharmaceuticals, Inc.

patents

4. 1 out of 61

Reata Pharmaceuticals, Inc.

patents

5. 1 out of 1

Enata Pharmacueticals, Inc.

patent

where one patent can have more than one assignee

Years Active: 2010-2016

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9493506 - Macrocyclic hepatitis C serine protease inhibitors (2016-11-15),

2. 9464082 - Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators (2016-10-11),

3. 9309279 - Macrocyclic hepatitis C serine protease inhibitors (2016-04-12),

4. 8951964 - Phenanthridine macrocyclic hepatitis C serine protease inhibitors (2015-02-10),

5. 8748374 - Macrocyclic hepatitis C serine protease inhibitors (2014-06-10),

6. 8642538 - Macrocyclic hepatitis C serine protease inhibitors (2014-02-04),

7. 8497275 - HCV protease inhibitors and uses thereof (2013-07-30),

8. 8420596 - Macrocyclic hepatitis C serine protease inhibitors (2013-04-16),

9. 8338605 - Anti-viral compounds (2012-12-25),

10. 7915411 - Anti-viral compounds (2011-03-29),

11. 7910595 - Anti-viral compounds (2011-03-22),

12. 7763731 - Anti-viral compounds (2010-07-27),

Title: Jason P Shanley: Innovator in Pharmaceutical Chemistry

Introduction

Jason P Shanley is a prominent inventor based in Chicago, IL (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for treating various diseases. With a total of 12 patents to his name, Shanley has established himself as a key figure in innovation within the pharmaceutical industry.

Latest Patents

Among his latest patents, one notable invention is related to macrocyclic hepatitis C serine protease inhibitors. This invention focuses on novel macrocyclic compounds and methods for treating hepatitis C infections. The patent also includes pharmaceutical compositions that comprise these compounds, along with acceptable carriers or excipients. Another significant patent involves aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones, which serve as antioxidant inflammation modulators. This application details compounds that can be used for the treatment and prevention of diseases associated with oxidative stress and inflammation.

Career Highlights

Throughout his career, Jason P Shanley has worked with leading companies in the pharmaceutical sector, including AbbVie Inc. and Abbott Laboratories Corporation. His work in these organizations has allowed him to contribute to groundbreaking research and development in drug formulation and therapeutic applications.

Collaborations

Shanley has collaborated with several notable professionals in his field, including Keith F McDaniel and Hui-Ju J Chen. These collaborations have further enhanced his research capabilities and have led to the successful development of innovative pharmaceutical solutions.

Conclusion

Jason P Shanley is a distinguished inventor whose work has significantly impacted the pharmaceutical industry. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.